throbber
Trials@uspto.gov
`571-272-7822
`
`
`
`
`
`Paper # 31
`Entered: February 16, 2022
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`__________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________
`
`APPLE INC.,
`Petitioner,
`
`v.
`
`MASIMO CORPORATION,
`Patent Owner.
`__________
`
`
`IPR2020-01523
`Patent 8,457,703 B2
`__________
`
`Record of Oral Hearing
`Held: January 19, 2022
`___________
`
`
`
`
`Before JOSIAH C. COCKS, ROBERT L. KINDER, and
`AMANDA F. WIEKER, Administrative Patent Judges.
`
`
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`
`APPEARANCES:
`
`ON BEHALF OF THE PETITIONER:
`
`
`WALTER KARL RENNER, ESQUIRE
`DAN SMITH, ESQUIRE
`KIM LEUNG, ESQUIRE
`Fish & Richardson
`1000 Maine Avenue, S.W.
`Washington, D.C. 20024
`
`
`
`
`ON BEHALF OF PATENT OWNER:
`
`
`JOSH STOWELL, ESQUIRE
`Knobbe, Martens, Olson & Bear, LLP
`2040 Main Street
`Irvine, CA 92614
`
`
`
`
`The above-entitled matter came on for hearing on Wednesday,
`January 19, 2022, commencing at 12:39 p.m., EDT, at the U.S. Patent and
`Trademark Office, by video/by telephone, before Chris Hofer, Notary
`Public.
`
`
`
`
`
`2
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`
` P R O C E E D I N G S
`- - - - -
`JUDGE COCKS: Welcome back everyone. This is the second
`
`session of our marathon oral hearing session today. I am Judge Cocks and
`again I'm joined by Judge Wieker and Judge Kinder. This oral argument
`session pertains to IPR2020-01523 involving patent 8,457,703. Would
`counsel for Petitioner who will be arguing their side today, will they please
`introduce themselves?
`
`MR. RENNER: Yes, Your Honor. This is Karl Renner. I am joined
`today by Dan Smith and Kim Leung and I'll be presenting primarily. Thank
`you.
`
`JUDGE COCKS: Thank you, Mr. Renner, and will counsel for Patent
`Owner who will be arguing in this session please identify themselves.
`MR. STOWELL: Hello, Your Honor. This is Josh Stowell from
`Knobbe, Martens and I will be arguing on behalf of the Patent Owner,
`Masimo.
`JUDGE COCKS: All right. Thank you, Mr. Stowell. So, we had
`provided for this session 40 minutes per side. Again, Petitioner will go first
`and may reserve rebuttal time. Patent Owner will then argue their
`opposition to Petitioner's case and may reserve surrebuttal time, and then
`Petitioner will use their rebuttal time and we will conclude with Patent
`Owner arguing their surrebuttal. So, with that said, Mr. Renner, you may
`begin whenever you are ready.
`MR. RENNER: Thank you, Your Honor, and I'll reserve ten minutes
`if I may.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`
`
`
`
`3
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`JUDGE COCKS: Yes. Thank you.
`MR. RENNER: You're welcome. Well, good afternoon, Your
`Honors. I'm Karl Renner as I mentioned and I'm here on behalf of Apple.
`May it please the Court. Today we plan to address the Diab-based grounds
`first. We're going to defer the conversation of the construction of
`predetermined characteristics until addressing the Amano grounds given the
`relevance of that construction to the Amano grounds.
`If I could go to slide 4, please. On slide 4 we show the claims 1 and
`9, the independent claims 1 and 9, which are largely redundant of one
`another and I'll just talk to them briefly to orient us at the outset here. The
`preamble indicates a focus on managing power consumption during a patient
`monitoring and the first two steps implicate driving light sources to emit
`light into tissue and receiving signals attenuated by that tissue as impacted.
`Then the claim goes on to talk about transitioning from a lower power
`consumption level to a higher consumption level when processing
`characteristics are said to pass a predetermined threshold. Claims 9 and 1
`defer in one specific area and that has to do with what happens in the lower
`power consumption level and that is in claim 1 it calls for reduced sensor
`activation but claim 9 speaks instead of signal processor processing.
`Go to slide 12, please, we'll turn into the Diab reference and speak to
`the combination by doing so. Diab is similar to the claims of '703 device as
`it emits light into tissue and it detects the lights attenuated from that tissue
`and it uses that detector attenuation of light to deduce physiological
`measurements for a specific patient (phonetic). Diab addresses two kinds of
`unhelpful artifacts, noise, that may be present in the detected light. The first
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`4
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`is described as an artifact resulting from, for instance, respiration. It's a low
`frequency type of an artifact. It's not relevant to our claim's mapping.
`The second is where we spend the time in the record and that's where
`we focus because it's an artifact that's introduced by patient movement, said
`to be erratic unlike that low frequency that's done with the respiration and
`the difference between these two noises or artifacts is yielded in the
`treatment that they get that's different in Diab.
`If we look at slide 13, please, we'll see at the bottom figure 20 is
`annotated and shows how Diab addresses these kinds of noises. The low
`frequency artifact, those unrelated to motion, are shown as the signal passes
`with the green line in the top part of this figure. It's an infrared light type
`noise or artifact and it's processed along this path and it's processed along
`this path with a DC bandpass filter in a spectral estimation module.
`The erratic motion artifacts, those ones that have to do with motion,
`these are characteristics that appear in the red and the ultrared light and
`they're otherwise addressed in the processing path that's shown in purple at
`the bottom and kind of throughout. Most notoriously though, this includes
`the namesake element, the motion artifact suppression module 580 that's
`going to get a lot of conversation today. But it also includes corresponding
`spectral estimation module 588 and there doesn't seem to be controversy at
`this level of detail. Where the controversy comes in is when examining that
`purple path and assessing what Diab does in the absence of motion. Does
`Diab continue to process motion artifacts and suppress them? Does it do the
`processes that are otherwise called for by its namesake in doing that in the
`absence of motion or does it continue?
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`5
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`According to Masimo the show goes on and that module is going to
`continue to process and it's going to continue to absorb processing cycles
`and therefore power and we don't believe that's true at all. We believe that
`there's an in input too that we'll talk a lot about that would tell that device to
`do something different to modify its processing and therefore have a
`corresponding modification in the power that's consumed as a consequence
`and this is based on the express disclosure found in Diab as well as
`inferences that are drawn from it in other statements.
`But let's look at Diab pretty closely if we could as we're talking to this
`and there's a couple of excerpts you can see at the top of this slide. The top
`and the top left quotes immediately follow from one another in the
`specification, both are referencing the same section and they speak to the
`what happens in each of the circumstances. I'm going to address them in the
`order they're listed on this slide although they are opposite in the actual
`specification of Diab. But it says in the case of motion motion artifacts are
`suppressed. There's no real mystery to that. But they also say that if motion
`is not detected it tells us what happens here. It says spectral estimation on
`the signals is carried out without motion artifact suppression. The key here
`is Diab's use of the word without. It describes what happens when motion is
`not detected. Spectral estimation of signals is carried out without motion
`artifact suppression. Motion artifact suppression does not occur. This is
`Diab's disclosure expressly. It couldn't be more clear.
`Now also in Diab there's a great number of instances where it speaks
`more affirmatively to the actual performance of motion suppression and in
`doing so we believe it draws out what negative inference that you don't
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`6
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`perform that same suppression in the absence of motion. An example of this
`would be found, for instance, at Diab 48, 34 to 36 and I'll quote,
`"In the case of motion, a motion artifact suppression is completed."
`Now this is an affirmative indication. But we believe there's a
`negative inference from it. Why would you specify in the case of motion if
`not suggesting at least rendering obvious to those of skill that in the absence
`of motion the opposite would happen.
`Slide 14, please. For fear of beating a dead horse the point is also
`reinforced we believe by Diab's disclosure of input from its motion status
`module 584 to the motion artifact suppression module 580 and this is shown
`at the bottom left of the prior figure. Motion status module 584 we know
`generates an output reflecting the presence or the absence of motion and it
`provides a trigger therefore for additional motion artifact suppression
`module and the processing that's done by it. Dr. Anthony credibly testifies
`that motion status input to the motion artifact suppression module must have
`a purpose and one of skill would find it obvious in view of Diab's other
`disclosure as well as the namesake of module 580 itself that it foregoes
`motion artifact suppression processes when informed of no motion and in
`this way the naming conventions themselves given by Diab's further
`disclosure by Diab of exactly what's going on when read in light of this
`motion status indication. Of course, this is an obviousness inquiry and this
`is a rhetorical issue. Why wash a car if the car isn’t dirty? Why clean, why
`perform the processing on a motion artifact laden signal, there is no motion
`and this is what Diab is telling us.
`Even Masimo offers tellingly helpful rhetoric on this. In its Patent
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`7
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`Owner response, it confirms that operations are different in light of motion
`or lack thereof by Diab. I'll quote, the modules, "operate differently based
`on motion status input." There's no rational basis offered alongside of this
`by Masimo to distinguish modules 590 and 94 that are implicated by that
`statement from 580. Instead, they maintain for whatever reason that the
`module continues in its way regardless of whether the motion is there or not
`and we can see in Diab that there's none.
`Slide 15, please. As shown by figure 21 that's annotated at the bottom
`of this figure you can see, and Anthony has testified to this in paragraph 54
`incidentally, that the motion artifact suppression module of Diab has
`components whose functions in red are useful for motion suppression but
`has other components that are only partially devoted to this function because
`they're not useful to it and therefore don't process data, but they process data
`regardless of motion. So, some of its components that are internal would
`naturally be affected by lack of motion because they're devoted to getting rid
`of motion artifacts. Others might still operate. It's hard to know. What we
`do know is the obviousness theories that have been set forth suggest that
`either you shut down that module, you suspend its operation all together or
`you shut down at least the portions of processing that are devoted to motion
`suppression.
`Slide 17, please. With all this why does Masimo maintain -- why are
`we talking about this -- why do they maintain that even if motion were
`absent a POSITA would not find it obvious to forego the processing that is
`specifically designed to eliminate motion inspired artifacts. Well, in the
`figure you see here, figure 20, you can see there's a lead line that shows out
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`8
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`as a clean plethysmograph waveform at the bottom, it's labeled and
`highlighted. Masimo goes further than just identifying a lead line. They
`draw some conclusions that we think are fairly incredible and unsupported,
`two of which stand out. One, that a POSITA would have considered the
`generation of that clean plethysmograph waveform by the motion artifact
`suppression module 580 a critical feature of Diab and two, that because
`that's a critical feature that a person would not modify Diab in any way that
`would affect the generation of that signal or the availability of that signal in
`that spot.
`Now let's unwind this. First, accepting Masimo's argument that
`generation by 580, module 580, of a clean plethysmograph wave form is
`essential to Diab if we accept that, which we do not, but for the purposes of
`the argument if we accept that Masimo still fails to account for contentions
`that a POSITA would find it obvious to suspend performance of processes
`after which module 580 is named, the ones that deal with motion artifact
`suppression in the absence of motion and to be clear about this point, recall
`figure 21 -- we just saw it -- which showed that several of the module 580
`sub-components, there's a DC band filter and a bandpass filter but they're not
`fully devoted to artifact suppression so it's possible that you could suppress
`the activities, the motion artifact suppression, you could suspend those and
`nevertheless still get to a place where the lead line would be present and
`that's not addressed in the arguments that they've given us.
`Now another issue with this is, to be clear, Masimo's critical feature
`theory is just itself unsustainable. Masimo's theory turns on the notion that
`that waveform is critical to the teaching of Masimo but when you look at
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`9
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`Masimo -- Diab, when you look at Diab beyond figure 20 there's scant
`mention of exactly what that is, why it's there and frankly that it's only there
`and we know that that's not the only place you can find a clean
`plethysmograph waveform. What you find at that spot as highlighted -- and
`let's go back to that (indiscernible) figure 20, it's on slide 17 -- you can see
`that it's cleaned of motion. That's the point of putting the lead line here. It's
`to show someone of skill reading this that you can find clean
`plethysmograph waveforms after this because you clean it in the presence of
`motion. But in the absence of motion, why would you go through the
`processing that's otherwise devoted to cleaning out motion? You find the
`clean plethysmograph waveform available wherever. This is something
`that's well understood by people of skill. There's no motion error to clean
`out and the only difference between the output of this module and the input
`of it is that you've cleaned out that motion that no longer exists or the
`artifacts no longer exist in the absence of motion.
`So, their contentions seem to be that because figure 20 shows an
`opportunity to obtain this waveform at the spot where it's shown, that it
`wouldn't be obvious for a POSITA to forego having the module perform
`processing operations that are specifically designed for cleaning of motion
`artifacts and we think this defies logic. Again, why would you run a car
`that's clean through a car wash?
`If we could jump to slide 19, please. Starting at the bottom --
`JUDGE COCKS: Actually, I have a question, Mr. Renner.
`MR. RENNER: Yes.
`JUDGE COCKS: Can we go back to slide 13? That would illustrate
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`10
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`my question better. So, I think I heard you suggest -- well, let me ask. The
`infrared signal that's shown in green there, there are occasions when it goes
`through motion artifact suppression and times that it does not; is that
`accurate?
`MR. RENNER: The green signal does not. Sorry, the green signal is
`free of --
`JUDGE COCKS: The green signal --
`MR. RENNER: -- the, oh, sorry.
`JUDGE COCKS: So, I guess my question then is I think you're
`suggesting that the purple signal from what's called the red snapshot, if that
`could pass through the motion artifact suppression module without
`undergoing motion artifact suppression; is that accurate?
`MR. RENNER: That is accurate. That's one thing that could happen
`and in order of course -- there are several different things spoken to in the
`record as to what a person of skill would find. But, Your Honor, I think
`you're asking is that possible and the answer is we believe so.
`JUDGE COCKS: So, I guess my question then is what is the purpose
`of figure 20 in showing the infrared snapshot, the green, not passing through
`the motion artifact suppression if that module can be turned off for motion
`artifact suppression? I guess, what is the entire purpose of that upper
`schematic portion dealing with infrared snapshot if it would pass -- if it
`could pass through the motion artifact suppression module without
`undergoing motion artifact suppression?
`MR. RENNER: Yes. Great question. That goes back to, you'll recall
`I mentioned that the Diab reference speaks of two different kinds of noise
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`11
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`and the kind of noise that we're spending all of our time with is the motion
`artifacts noise that needs to be suppressed. So, in the existence of motion
`you want to suppress the artifacts that are motion laden and that's what the
`580 module and the purple path does.
`But there's a second kind of noise that Diab is speaking to in its
`disclosure and that's noise that comes of respiration and other low frequency
`effects on the blood. Those effects are filtered out in the green. So in the
`absence of motion, you need not pursue all of the processing that it
`contemplates on motion artifacts but you still might have, in fact you
`probably have, other artifacts, the ones that are respiratory in nature and
`those are going to pass through different filters as you can see in different
`processing to get rid of them and then they all will under the spectral
`analysis collectively which is where you can see the green and the purple
`come together in the presence of motion. Does that help? So, kind of there's
`two different kinds of noise --
`JUDGE COCKS: I understand your answer.
`MR. RENNER: Uh-huh.
`JUDGE COCKS: Okay. Go ahead. Thank you.
`MR. RENNER: Sure. So, we were at slide 19, if I may, and here we
`were looking at testimony from Dr. Anthony that concerns the notion that
`the motion suppression is not necessary and it's the why drive your car
`through a car wash. He says, and this is in response to questions in the
`deposition, if motion is not present we need not remove it to generate the
`clean plethysmograph signal and this is at the transcript at 68, 15 to 69, 6.
`Now we expounded upon that. That was of course his deposition
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`12
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`early on. There was no mention of this in the brief where the critical theory
`was introduced. Instead, this was not regarded and we talked about that in
`our Petitioner's reply at 4 and 7 and 8 and we'll leave that to the papers but
`the point being that there's very specific testimony here from Dr. Anthony
`that confirms the very concept of don't do something that's not necessary and
`that could be changing the processing, that could be shutting down the
`element all together.
`Without more, I would move to slide 25 and we'd start speaking about
`Amano's contribution. So generally, at slide 25 Amano is leveraged relating
`to its body movement eliminating operations. Sounds very familiar. These
`are designed to address motion artifacts also in a manner that's similar to
`what Diab just gave us with its motion artifact suppression module and
`Amano says, and I'll quote. This is from 21, 50 to 22, 6. It says,
`"When the control signal C," its control signal, "indicates that no body
`movement is present, the operations of the body movement component
`eliminating section are suspended."
`And then it goes on to say that this can "reduce power consumption in
`the apparatus." So much like Diab but a little more explicitly here, you see
`from Amano an indication that when you get a motion, a no motion signal,
`you shut down the operations that are devoted to getting rid of motion
`artifacts and when you do that, you get the side benefit of less processing
`equals less power consumption. This isn't really a tough concept but we
`wanted to have a reference in the combination that was express on this point,
`hence we have Amano.
`So it also talks about the relationship that exists between performance
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`13
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`of its movement eliminating operations therefore and the power
`consumption and it discloses that a POSITA similarly would commonly
`know that the power consumption is indeed increased when a device
`performs processing and power consumption is decreased when it foregoes
`the same, and more to the point therefore it teaches suspending in light of no
`motion and motion eliminating operation they didn't call for just like what
`Diab has said but in the context of, as Dr. Anthony explains, these two
`together it becomes even more evident and more obvious that what you're
`going to do in a system like Diab is you're going to stop the processing that's
`devoted to motion artifacts if indeed there is no motion.
`If we could go to slide 29, please. Now the obviousness of the
`combination of Diab and Amano is there's an attempt to undermine that
`based on details that are not part of the combination itself. Various different
`details you'll probably hear about, that have got really nothing to do with the
`combination of Amano. Keep in mind I want to be very clear on this, has
`been looked upon for very specifically its teaching of artifact suppression,
`motion artifact suppression, and shutting down the processing for that in the
`spirit of pursuing power consumption savings. Beyond that we're leaving
`Diab where it is in large part so the other details that are said to be
`conflicting as between them would have to amount to a teaching away or
`something along those lines and we would submit to you that the record just
`does not establish that kind of proof.
`To this point, none of the supposed incompatibilities between the
`device of Diab and Amano have bearing on the proposed combination. In
`fact, the devices described in Diab and Amano share many key features that
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`14
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`would lead someone to pull them together. Both them detect physiological
`parameters by emitting light through tissue and detecting attenuation. Both
`can be used in similar parts of the body, the finger for instance, both
`measure pulse rate and both teach selectively removing a body motion
`component, an artifact from the received light signal when motion is indeed
`present.
`Even if Amano's implementation details were somehow thought to
`render the teachings incompatible -- this is an important point we think --
`please note the back-up ground that's offered where Petitioner alternatively
`advanced the obviousness based on Diab in view of a POSITA's knowledge.
`In doing so we establish what a POSITA's knowledge is, not just on Amano
`although it is cited in support. We also cite seven different patents and
`they're all listed, you know, I could read them but they're in the record.
`They're all cited in support of establishing what a POSITA actually
`understood to be true and why it would in fact take Diab and modify it in a
`way that's objective (phonetic).
`Slide 30, please. Let's just go to slide 31. So Diab describes the
`motion status module 584 and it takes the average peak width as input and
`this has to do with predetermined threshold. So, one of the other arguments
`here is that there is no predetermined threshold, that the threshold that's used
`for assessing whether or not motion is the kind of motion that would albeit
`characteristic to trigger a transition, is at a predetermined threshold that it's
`compared against and there's a lot of noise made over that. So, we wanted to
`address this. Slide 31 is where we turn in doing so and we find that Diab
`describes that the motion status module 584, it takes an average peak width
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`15
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`as its input, it determines whether that average peak is wide -- it just says it's
`wide -- and it produces a signal indicating whether motion is present based
`on its determination of whether that signal actually reflected wide enough to
`be a motion.
`Dr. Anthony testifies about this and he says that a POSITA would find
`it obvious in light of Diab's disclosure to use the motion status model 584 to
`compare the average peak width to some sort of threshold value because you
`have to figure out whether or not why it exists and the absence of any
`indication here that there is real time processing or other processing that's
`necessary to go and figure out a new threshold to find out a threshold once
`you want to do the comparison, that itself tells that it's obvious that Diab has
`used indeed a predetermined threshold.
`Now I don't want to belabor this point too much. I just wanted to
`mention that predetermined, determined prior, there is no more by which this
`is connected to the claim other than it happens to sit in a step which is a step
`for comparison. So presumably we've predetermined, determined prior to
`the comparison, and surely that's what you get in Diab. It's looking for a
`way to evaluate in fact its peak and how it's going to assess whether or not
`it's a width and we know that in Diab, and we think it's fairly important, at
`column 34 lines 5 to 7 it shows us an example of when something isn't able
`to be predetermined. It tells the reader this, and I'll read it out loud. Again,
`34, 5 to 7. It says "erratic motion induced noise typically cannot be
`predetermined." This is the words in Diab. Point being where there are
`items in Diab that cannot be predetermined where its disclosure is not
`supposed to encompass predetermined it tells the reader about it with respect
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`16
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`to the why it did not do so and therefore leaves, we believe, the reader to
`understand what Dr. Anthony tells us he understood.
`If we could turn maybe to slide 47, I would turn to the Turcott ground
`briefly and I'd note that Turcott is relied upon in the briefing for balancing
`power consumption and signal-to-noise ratio based on adjustments in duty
`cycle and other adjustments with low duty cycle, for instance, used to
`improve power consumption at the cost of signal-to-noise ratio and a high
`duty cycle being used to improve signal-to-noise at the cost of power
`consumption. The point is Turcott offers us another theory. It's another
`combination, and the theory it offers is I know that I want to adjust power so
`as to create the right balance between signal-to-noise ratio and power and as
`a consequence I'm going to make changes to the system to reflect that and
`Diab, the primary reference, dictates real time processing and adjustments in
`real time are used for detection of movement. So Diab brings the real time
`nature of the table and Turcott is merely, although there are contentions
`otherwise being used to add the flexibility of signal-to-noise ratio as a
`comparative of power consumption, and with that it offers that you can
`change power in any of a variety of ways that are relied upon. It's the
`flexibility that Diab is after though.
`Dr. Anthony explains, if we look at slide 48, that a POSITA would
`have found it obvious to modify Amano as well as Diab because a
`modification by Turcott would allow for a modification of the current duty
`cycle pulse training applied to the LED of the sensor in the same way and
`therefore there'd be reduced activation of the attached sensor, much as the
`theory was the for the Diab combination.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`17
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`On slide 52, if we can move to it, we can see that Diab/Amano, they
`offer adjustments during monitoring but to be clear, they don't rely on
`Turcott. They won't agree that, sorry, that Turcott would be seen by a
`POSITA as limited to a factory setup or anything else. It's a real time -- its
`integration would be into a real time system and there's no reason why you
`couldn't integrate it as said.
`There was a contest that Turcott was said to be limited to surgical
`implants in an attempt to establish that it wouldn't be obvious to integrate its
`teachings into a real time monitoring type system. Surgical implant of
`course would be put in the body, you may have a hard time adjusting things.
`But this couldn't be further from the truth.
`Slide 56 if we look at it shows us that Turcott explicitly discloses that
`its teachings apply to non-invasive pulse sensors so when you encounter that
`argument, we submit that to you.
`With that I would jump to Amano itself and close my direct by talking
`a little about the combination and then the construction that relates to that
`but before I do that, are there questions about Diab and its combinations
`with Amano or Turcott that I could address before I turn there?
`JUDGE COCKS: No, I think you can. We may have questions at
`some later time but you have about three minutes so why don’t you finish
`your direct presentation in those three minutes.
`MR. RENNER: Thank you, Your Honor. So, slide 35 is where I was
`directing us. Amano teaches of course this physiological monitor operating
`based on the same principles of the '703 patent as Diab with emitting light
`into the user tissue to determining if physiological measurement value is
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`
`
`18
`
`

`

`IPR2020-01523
`Patent 8,457,703 B2
`based on that attenuation and like Diab it (indiscernible) move motion, we've
`talked about this already. The difference that we are going to talk about is it
`uses an accelerometer to detect motion rather than influencing it or inferring
`it from a light signal. In Diab we infer from a light signal what motion
`existed here. It's an accelerometer that bears that out and that difference
`forms the crux of Masimo's attack on it and its attempt to leverage the term
`processing characteristic. You'll note that the trigger was formed by virtue
`of the processing characteristic being part of a comparison to that
`predetermined threshold.
`So, what is a processing characteristic? If we go to slide 7. What we
`can see here is that Masimo's construction was that the processing
`characteristic is to require the characteristics determined from a signal
`received from one or more detectors configured to detect light. So,
`something's that determined from a signal, received from one or more
`detectors that are configured to detect light and that's what they're reading
`into the words processing characteristic. We think that plain meaning does
`the trick to what we had alleged at the front end and we don't see reason to
`move from that.
`Looking at their construction we think it's improper. It injects
`unclaimed subject matter from the specification into the claim. It usurps the
`amendment process in doing so. If they had wanted more de

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket